Hjem › Blærekreft › Maryland
Kliniske studier for Blærekreft i Maryland
36 studier for Blærekreft søker deltakere på steder i Maryland.
Byer i Maryland
Offisiell studietekst (engelsk)
Evaluation for NCI Surgery Branch Clinical Research Protocols
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT00001823En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudie
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04235764Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- FMH James M Stockman Cancer Institute, Frederick
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- og 10 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06172478Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 2 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT00026884Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- National Institutes of Health Clinical Center, Bethesda
- FMH James M Stockman Cancer Institute, Frederick
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382DK222 Study at Hopkins
- Johns Hopkins Hospital, Baltimore
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07140315Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Oncology Research Pharmacy and lnvestigational Drug Service, Baltimore
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Johns Hopkins Hospital, Baltimore
- og 2 flere
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07421700A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Johns Hopkins University ( Site 0843), Baltimore
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07419295A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Johns Hopkins Hospital, Baltimore
- James M Stockman Cancer Institute, Frederick
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07218380Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Anne Arundel Urology, Annapolis
- Chesapeake Urology Research Associates, Hanover
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06567743The Vanguard Study: Testing a New Way to Screen for Cancer
- Walter Reed National Military Medical Center, Bethesda
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 45 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06995898Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 120 · Alle kjønn · Oppdatert 28. aug. 2026 · NCT02379429FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Johns Hopkins Kimmel Cancer Center, Baltimore
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT05614739Measuring Surgical Recovery After Radical Cystectomy
- John Hopkins Medical Institutions, Baltimore
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT03193970A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT04923178LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- John Hopkins Hospital, Baltimore
- Chesapeake Urology Research Associates, Hanover
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. aug. 2026 · NCT04752722Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Johns Hopkins Hospital, Baltimore
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jul. 2026 · NCT07106762A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- The John Hopkins Hospital, Baltimore
- Maryland Oncology Hematology- Columbia, Rockville
RekruttererFase 2
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Chesapeake Urology Research Associates, Hanover
Rekrutterer
Alder 18 til 88 · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06394869Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Frederick Health Hospital, Frederick
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07327489Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. jun. 2026 · NCT0531267118F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 120 · Alle kjønn · Oppdatert 19. mai 2026 · NCT06503146Bladder EpiCheck Product Development Study
- Chesapeake Urology Research Associates, Towson
RekruttererObservasjonsstudie
Alder 22 og eldre · Alle kjønn · Oppdatert 7. apr. 2026 · NCT07514143A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2026 · NCT06778863Renal Retention in High Grade Upper Tract Urothelial Cancer
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 8. jan. 2026 · NCT05656235Image-Guided Gynecologic Brachytherapy
- The SKCCC at Johns Hopkins, Baltimore
Rekrutterer
Alder 18 til 100 · Kvinner · Oppdatert 18. des. 2025 · NCT02993900Blue Light Cystoscopy With Cysview® Registry
- Johns Hopkins Medicine, Baltimore
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 18. des. 2025 · NCT02660645Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Hospital, Baltimore
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 20. nov. 2025 · NCT07225205Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
- Johns Hopkins University School of Medicine, Baltimore
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 18. nov. 2025 · NCT06525571Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
- Johns Hopkins Hospital, Baltimore
Rekrutterer
Alder 18 og eldre · Menn · Oppdatert 18. nov. 2025 · NCT05792722SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- og 1 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Gender Related Coping and Survivorship for Genitourinary Cancers
- Johns Hopkins Hospital, Baltimore
RekruttererObservasjonsstudie
Alder 18 og eldre · Kvinner · Oppdatert 3. okt. 2025 · NCT05649306Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.